Home

biotechnology

India Halts Plan for Engineered Eggplant

KRISHNA POKHAREL The Wall Street Journal 02/09/2010

Senate panel gives 12-year exclusivity to biotech drugs

Christine McConville Boston Herald 07/14/2009
India Halts Plan for Engineered Eggplant

NEW DELHI—India put on ice its plans to allow the commercial cultivation of genetically modified eggplant after facing opposition from states and environmental groups, in a case that has been viewed as a litmus test for whether the government would embrace genetically modified crops to bolster food production.

Senate panel gives 12-year exclusivity to biotech drugs

Biotechnology companies are cheering a U.S. Senate committee decision that would give them 12 years before they have to share their drug data with competitors.